Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
al, annum, ascribe, Bookkeeping, boundary, caution, Christoph, CRL, derecognition, disagree, eleva, erythema, explained, FFDCA, ID, Inline, ITT, landscape, multicenter, multinational, occasion, PP, prompt, Rapporteur, Removal, resolution, resubmission, resubmitted, role, sector, unchanged, upcoming, verification, Wainwright, Wanner, worth
Filing tables
Filing exhibits
Related press release
Associated PLX transcripts
PLX similar filings
Filing view
External links
| |
| Exhibit 23.1 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-230604 and 333-237736) and on Form S-8 (No. 333-148983, No. 333-182677, No. 333-203960, No. 333-225526 and No. 333 239101) of Protalix BioTherapeutics, Inc. of our report dated March 31, 2022 relating to the financial statements, which appears in this Form 10-K.
X, 2022 | |
Tel-Aviv, Israel March 31, 2022 | /s/ Kesselman & Kesselman Certified Public Accountants (lsr.) A member firm of PricewaterhouseCoopers International Limited |
| |